檢索結果 - Weidong Han

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Balance and management of CRS and infection following CD19-targeted CAR T-cell therapy in primary refractory high-grade B-cell lymphoma: a case report Nannan Lu, Nannan Lu, Yajing Zhang, Chunmeng Wang, Qingming Yang, Guanghua Rong, Yang Liu, Weidong Han, Weidong Han

    出版 2025-07-01

    BackgroundCD19-targeted chimeric antigen receptor T (CAR T) cell therapy has revolutionized the treatment of refractory/relapsed B-cell malignancies. However, this therapy introduces significant safety concerns, including cytokine release syndrome (CRS) and infections, both of which can lead to life...

    全面介紹

    獲取全文
    Article
  2. 2

    Hyponatremia predicts immunotherapy resistance in biliary tract cancer Tiance Wang, Zijian Lv, Runjia Fan, Weidong Han, Qian Mei

    出版 2025-12-01

    Hyponatremia, a common electrolyte imbalance in cancer patients, has frequently been disregarded in terms of its prognostic implications for immunotherapy. This study examined the prognostic implications of pre-treatment hyponatremia in patients with biliary tract cancers (BTC) undergoing immunother...

    全面介紹

    獲取全文
    Article
  3. 3

    Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence Zhuoxuan Wu, Zhen Liu, Weiting Ge, Jiawei Shou, Liangkun You, Hongming Pan, Weidong Han

    出版 2018-06-01

    Abstract This study aimed to identify differentially expressed genes (DEGs) related to the colorectal normal mucosa–adenoma–carcinoma sequence using bioinformatics analysis. Raw data files were downloaded from Gene Expression Omnibus (GEO) and underwent quality assessment and preprocessing. DEGs wer...

    全面介紹

    獲取全文
    Article